CANCER RESEARCH INSTITUTE INC
Income Statement
Fiscal Year Start:
Jul 1
Revenues in 2024
$23,964,638
Contributions
78%
Other
11%
Fundraising Events
6%
Investments
5%
Government Grants
0%
Program Services
0%
Membership Dues
0%
Expenses in 2024
$32,820,896
Grants
68%
Salaries & Benefits
16%
Fees to Service Providers
6%
Other
4%
Offices, Occupancy & IT
4%
Advertising & Promotion
<1%
Depreciation
<1%
Benefits to Members
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$29,722,933
$18,691,591
-37%
Government Grants
$0
$0
-
Fundraising Events
$1,297,284
$1,451,713
+12%
Program Services
$0
$0
-
Membership Dues
$0
$0
-
Investments
$644,951
$1,102,600
+71%
Other
$630,091
$2,718,734
+331%
Total Revenues
$32,295,259
$23,964,638
-26%
Expenses
2023
2024
Change
Grants
$27,521,822
$22,471,018
-18%
Benefits to Members
$0
$0
-
Salaries & Benefits
$5,330,368
$5,354,714
+0%
Fees to Service Providers
$1,576,472
$2,102,100
+33%
Advertising & Promotion
$224,254
$216,155
-4%
Offices, Occupancy & IT
$726,068
$1,201,868
+66%
Interest
$0
$0
-
Depreciation
$41,992
$41,983
0%
Other
$3,131,687
$1,433,058
-54%
Total Expenses
$38,552,663
$32,820,896
-15%
Net income
2023
2024
Change
Net income
-$6,257,404
-$8,856,258
-42%
Functional Expenses
Summary
2023
2024
Change
Program
$32,845,229
$26,628,724
-19%
Admin
$2,079,619
$2,746,561
+32%
Fundraising
$3,627,815
$3,445,611
-5%
Total Expenses
$38,552,663
$32,820,896
-15%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)